公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 RADIM LATINO AMERICA DIAGNOSTICO LTDA.取消

29 记录

产品持有公司班级有效性
17-ALFA-HIDROXIPROGESTERONA80103990074RADIM LATINO AMERICA DIAGNOSTICO LTDA.II现有
ANALISADOR AUTOMATICO80103990001RADIM LATINO AMERICA DIAGNOSTICO LTDA.II现有
ANALISADOR AUTOMATICO80103990046RADIM LATINO AMERICA DIAGNOSTICO LTDA.II现有
ANALISADOR AUTOMÁTICO BRIO 280103990080RADIM LATINO AMERICA DIAGNOSTICO LTDA.II现有
ANDROSTENEDIONA80103990072RADIM LATINO AMERICA DIAGNOSTICO LTDA.II现有
ANTISORO ANTI-FIBRINOGENIO HUMANO80103990050RADIM LATINO AMERICA DIAGNOSTICO LTDA.II现有
ANTITROMBINA III80103990066RADIM LATINO AMERICA DIAGNOSTICO LTDA.II现有
APOLIPOPROTEINA CALIBRADOR (N)80103990051RADIM LATINO AMERICA DIAGNOSTICO LTDA.II现有
APOLIPOPROTEINA CONTROLES (N)80103990056RADIM LATINO AMERICA DIAGNOSTICO LTDA.II现有
BRIO - OPERADOR ROBOTICO BASICO DE IMUNOENSAIO80103990045RADIM LATINO AMERICA DIAGNOSTICO LTDA.II现有
CALIBRADOR PROTEÍNA P (N)80103990057RADIM LATINO AMERICA DIAGNOSTICO LTDA.II现有
CONTADOR AUTOMATICO DE CELULAS80103990060RADIM LATINO AMERICA DIAGNOSTICO LTDA.II现有
CONTROLE ALBUMINA LIQUOR80103990071RADIM LATINO AMERICA DIAGNOSTICO LTDA.II现有
CONTROLE ALBUMINA URINARIA80103990068RADIM LATINO AMERICA DIAGNOSTICO LTDA.II现有
CONTROLE CRP ULTRA-SENSIVEL80103990070RADIM LATINO AMERICA DIAGNOSTICO LTDA.II现有
CONTROLE IgG URINÁRIO/ LIQUOR80103990069RADIM LATINO AMERICA DIAGNOSTICO LTDA.II现有
CONTROLE PROTEÍNA P (N)80103990058RADIM LATINO AMERICA DIAGNOSTICO LTDA.II现有
CONTROLE TRANSFERRINA URINÁRIA80103990067RADIM LATINO AMERICA DIAGNOSTICO LTDA.II现有
FERRITINA80103990062RADIM LATINO AMERICA DIAGNOSTICO LTDA.II现有
FT4 EIA WELL80103990087RADIM LATINO AMERICA DIAGNOSTICO LTDA.II现有
HAV Ab80103990059RADIM LATINO AMERICA DIAGNOSTICO LTDA.II现有
IgE80103990063RADIM LATINO AMERICA DIAGNOSTICO LTDA.II现有
LEITORA AUTOMATICA DE MICROPLACAS80103990064RADIM LATINO AMERICA DIAGNOSTICO LTDA.II现有
Lp (a)80103990049RADIM LATINO AMERICA DIAGNOSTICO LTDA.II现有
Lp(a) CALIBRADOR (N)80103990048RADIM LATINO AMERICA DIAGNOSTICO LTDA.II现有

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家